| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Gowen Maxine serves as a Director at ACRS and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 0 buys and 1 sell. Those positions are worth an estimated $291K at current prices.
The biggest single holding is AKBA (~$291K) as Director. The recent filings there lean toward selling, a net 4,567 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 8, 2020 | AKBA Akebia Therapeutics, Inc. | Director | Sell | 4,567 | $12.05 | $55,032.35 | -15.9% |